Laboratorios Farmaceúticos Rovi SA (LABFF)
65.86
0.00 (0.00%)
USD |
OTCM |
Dec 09, 16:00
Laboratorios Farmaceúticos Rovi Debt to Equity Ratio: 0.1988 for Sept. 30, 2025
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Grifols SA | 1.871 |
| Pharma Mar SA | 0.2548 |
| Oryzon Genomics SA | 0.0866 |
| Almirall SA | -- |
| CEL-SCI Corp. | 1.418 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.083B |
| Total Liabilities (Quarterly) | 339.89M |
| Shareholders Equity (Quarterly) | 730.54M |
| Current Ratio | 3.016 |
| Net Debt Paydown Yield | -0.09% |